7 - 9 November, 2022, In-person and Online event
The Global Pharmaceutical and Biotechnology Conference is the essential annual event to stay up to date with innovation and growth across the sector. Leaders in life sciences from around the world will convene in London to discuss the latest trends in areas such as drug discovery, clinical trials and market access, exploring new frontiers for business and for healthcare.
As a lead sponsor, ICON is pleased to offer senior executives at clients and other third parties, a 25% discount for this in-person and online event supported by the world's best journalism. Simply complete the short form and we will contact you.
|In-person pass||Digital pass|
Steve Cutler, CEO, ICON plc
Dave Ricks, Chair and CEO, Eli Lilly
Richard Saynor, CEO, Sandoz
Christophe Weber, President and CEO, Takeda
David Loew, CEO, Ipsen
Padraic Ward, Head of Pharma International, Roche
Stefan Oelrich, President, Bayer Pharmaceuticals
Amanda Pritchard, Chief Executive, NHS England
7 November 2022 - 11:55 AM - 12:10 PM GMT
Interview: More than a year after acquiring another large CRO and driving a successful integration strategy, hear how one company has enhanced its value proposition and its role in a rapidly shifting the clinical trials landscape in which the future could be many more trials delivered in shorter timeframes, but conversely of greater operational and scientific complexity.
VP, Decentralised Trials, ICON
Other panelists include: